Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Prosopagnosia01:24

Prosopagnosia

159
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
159
Visual System01:26

Visual System

579
Light enters the eye through the cornea, a transparent, dome-shaped surface covering the surface of the eyeball that helps to direct and focus incoming light. This light is then channeled toward the pupil, an adjustable opening whose size is controlled by the iris. The iris, a pigmented muscle, regulates the amount of light entering the eye by contracting or dilating the pupil, thereby ensuring optimal light levels for clear vision.
Once through the pupil, the light passes through the lens, a...
579
Vision01:24

Vision

53.2K
Vision is the result of light being detected and transduced into neural signals by the retina of the eye. This information is then further analyzed and interpreted by the brain. First, light enters the front of the eye and is focused by the cornea and lens onto the retina—a thin sheet of neural tissue lining the back of the eye. Because of refraction through the convex lens of the eye, images are projected onto the retina upside-down and reversed.
53.2K
Visual Agnosia01:12

Visual Agnosia

195
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
195

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Complement in Traumatic Brain Injury: Linking Acute Injury to Chronic Neurodegeneration.

European journal of immunology·2026
Same author

Targeted complement inhibition ameliorates the pathological and cognitive outcomes in repetitive mild closed head injury.

Signal transduction and targeted therapy·2025
Same author

Comparison of Outcomes of Transcatheter Edge-to-Edge Repair With Early Versus Latest Generation MitraClip for Severe Mitral Regurgitation.

Heart, lung & circulation·2025
Same author

Complement Modulation Mitigates Inflammation-Mediated Preterm Birth and Fetal Neural Inflammation.

Cells·2025
Same author

Luminal Vascular Dysfunction Drives Rapid Blood Brain Barrier Injury in Hyperglycemic Stroke: Key Roles for Luminal Glycocalyx and Complement.

bioRxiv : the preprint server for biology·2025
Same author

Tissue-targeted regulators of complement for amelioration of human disease: rationale and novel therapeutic strategies.

Journal of immunology (Baltimore, Md. : 1950)·2025

相关实验视频

Updated: Jun 28, 2025

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
04:02

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

Published on: November 29, 2024

1.1K

补充物在创伤性脑损伤后传播视觉系统病理.

Davis M Borucki1,2, Baerbel Rohrer3,4, Stephen Tomlinson5,6

  • 1Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.

Journal of neuroinflammation
|April 17, 2024
PubMed
概括

创伤性脑损伤 (TBI) 通过激活大脑中的补体和微质细胞,导致视力丧失. 抑制补充剂可以保护突触并改善TBI后的视力.

更多相关视频

Intravital Imaging of Fluorescent Protein Expression in Mice with a Closed-Skull Traumatic Brain Injury and Cranial Window Using a Two-Photon Microscope
08:25

Intravital Imaging of Fluorescent Protein Expression in Mice with a Closed-Skull Traumatic Brain Injury and Cranial Window Using a Two-Photon Microscope

Published on: April 21, 2023

1.1K
Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
11:14

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging

Published on: April 6, 2014

12.4K

相关实验视频

Last Updated: Jun 28, 2025

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
04:02

Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy

Published on: November 29, 2024

1.1K
Intravital Imaging of Fluorescent Protein Expression in Mice with a Closed-Skull Traumatic Brain Injury and Cranial Window Using a Two-Photon Microscope
08:25

Intravital Imaging of Fluorescent Protein Expression in Mice with a Closed-Skull Traumatic Brain Injury and Cranial Window Using a Two-Photon Microscope

Published on: April 21, 2023

1.1K
Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
11:14

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging

Published on: April 6, 2014

12.4K

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 眼科医生 眼科 眼科

背景情况:

  • 创伤性脑损伤 (TBI) 可以导致视觉系统的延迟和渐进性障碍.
  • 神经炎症,特别是补体系统的激活,与TBI的发病有关.
  • 补充剂在TBI引起的视力损失中的作用仍然未被探索.

研究的目的:

  • 研究补充激活在TBI引起的视力缺陷中的作用.
  • 为了检查补充抑制对神经炎症和突触完整性在TBI后后背侧生殖核 (dLGN) 和视网膜的影响.

主要方法:

  • 用于控制皮质冲击 (CCI) 的小鼠模型来诱导TBI.
  • 在TBI后评估了神经炎症,组织病理和视觉功能.
  • 使用抑制剂CR2-Crry. 的方法实现了补充抑制.

主要成果:

  • 创伤诱导了补充C3沉积和微质激活,并在DLGN中进行突触内化.
  • 补充抑制减少了微质突触吸收,并保持了突触密度.
  • 虽然视网膜结构保持不变,但DLGN神经病理与视力敏度降低相关,这种视力敏度随着补体抑制而改善.

结论:

  • 在DLGN中,TBI触发补充激活和微质介导的突触损失,导致视力受损.
  • 补充抑制可以减轻这些影响,保持突触完整性和视觉功能.
  • 针对补充系统为TBI相关的视力损失提供了潜在的治疗策略.